Clinical Trial Update: Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea

View source ↗

Summary

The update discusses findings from a completed study indicating insulin resistance as the primary pathogenesis in newly diagnosed, drug-naïve Type 2 diabetes pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED